About Mynvax Private Limited
Data last updated:
Mynvax Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 05 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2017PTC102838. Its GSTIN is 29AALCM0492J1Z0 (Karnataka).
The company has an authorised share capital of ₹13 Lakh and a paid-up capital of ₹6.04 Lakh. It is led by directors including Ganesh Murthy Kishore and Gautham Nadig.
Its last annual general meeting (AGM) was held on 06 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Brigade Mlr Centre No 50 3rd Floor Vani Vilas Road Basavanagudi, Bangalore, Karnataka, India – 560004.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.56 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹22.58 Cr and EBITDA of -₹21.61 Cr. Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 23% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mynvax. The company has 6 deals on record (5 funding rounds, 1 rights issue), with disclosed funding of ₹113.09 Cr; the latest was in May 2024. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Catalyst Clinical Services Private Limited with revenue of ₹3.71 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mynvax.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressBrigade Mlr Centre No 50 3rd Floor Vani Vilas Road Basavanagudi, Bangalore, Karnataka, India – 560004
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mynvax Private Limited
The main business activity of Mynvax is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mynvax Private Limited FY 2025 filings available
Mynvax Private Limited reported revenue of ₹3.56 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mynvax Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 26% growth in the latest year. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mynvax Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹21.61 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹22.58 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mynvax Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mynvax are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mynvax Private Limited
Mynvax Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Catalyst Clinical Services Private Limited | ₹3.71 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Delhi, India |
| Azantis Life Sciences Private Limited | ₹3.7 Cr (FY 2025) | •••• | •••• | 185.0% | •••• | Thane, Maharashtra, India |
| Elora Biosciences Private Limited | ₹3.69 Cr (FY 2023) | •••• | •••• | 763.0% | •••• | Ernakulam, Kerala, India |
| My Biotech Private Limited | ₹3.68 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Thane, Maharashtra, India |
| Genext Biotech Private Limited | ₹3.6 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Margao, Goa, India |
| Mynvax Private Limited this company | ₹3.56 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Bangalore, Karnataka, India |
| A A Biotech Private Limited | ₹3.56 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Chennai, Tamil Nadu, India |
| Sanvira Biosciences Private Limited | ₹3.56 Cr (FY 2025) | •••• | •••• | 1677.0% | •••• | Hyderabad, Telangana, India |
| Vecnost Biotechnology Private Limited | ₹3.54 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Amritsar, Punjab, India |
| Ingenomics Private Limited | ₹3.52 Cr (FY 2025) | •••• | •••• | 90.0% | •••• | New Delhi, Delhi, India |
| Swakit Biotech Private Limited | ₹3.51 Cr (FY 2025) | •••• | •••• | 89.0% | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Mynvax by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mynvax Private Limited
Mynvax Private Limited is audited by M D A & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M D A & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mynvax Private Limited
Mynvax has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganesh Murthy Kishore | Director | 29 Dec 2017 | 8 Years 9 Months | Current |
| Gautham Nadig | Director | 05 May 2017 | 9 Years 5 Months | Current |
| Mahendran Balachandran Also directs: Erasmic Investment Advisors LLP, Accel Partners India LLP, Accel India Advisors LLP and 5 more | Nominee Director | 07 Aug 2021 | 5 Years 2 Months | Current |
| Raghavan Varadarajan | Director | 05 May 2017 | 9 Years 5 Months | Current |
| Arun Suresh Chandavarkar Also directs: Biocon Biologics Limited, Biocon Research Limited | Director | 01 Jan 2021 | 5 Years 9 Months | Current |
| Anil Gudibande Also directs: Sanaka India Advisors LLP, Hoi Food Concepts Private Limited, Parijat Industries (India) Limited and 5 more | Director | 16 Oct 2019 | 6 Years 11 Months | Current |
Ownership and Shareholding of Mynvax Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mynvax Private Limited
Mynvax Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Mynvax Private Limited
Mynvax Private Limited has 6 deals on record (5 funding rounds, 1 rights issue), with disclosed funding of ₹113.09 Cr; the latest was in May 2024.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2024 | Funding round · Series A | ₹21.63 Cr | Investors: Inviga Investment Advisors, Legacy Assets LLP |
| Aug 2021 | Funding round · Series A | ₹30.87 Cr | Investors: Accel India, LVX (LetsVenture), 2 individuals |
| Jul 2020 | Funding round | ₹7.5 Cr | Investors: an individual |
| Oct 2019 | Funding round · Seed | ₹8.37 Cr | Investors: Kotak Private Equity, 1Crowd Fund, 2 individuals |
| Nov 2018 | Rights issue | ₹5.35 Cr | Investors: Nadig Advisors Private Limited , 3 individuals |
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Mynvax Private Limited
Mynvax operates one associated brand: Mynvax. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Novel recombinant vaccines against influenza and COVID-19 are developed. | mynvax.com |
Employees and EPFO Compliance at Mynvax Private Limited
Mynvax Private Limited has a workforce of 26 employees as of Apr 10, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Mynvax Private Limited
Recent Activity on Mynvax Private Limited
Mynvax Private Limited has 10 board changes on record since 2017: 6 appointments and 4 cessations. The latest: Mahendran Balachandran was appointed as Nominee Director on 07 Aug 2021.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mynvax Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mynvax Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mynvax Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mynvax Private Limited
Mynvax has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCM0492J1Z0 | Karnataka | Active | 09 Mar 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mynvax Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mynvax Private Limited
Mynvax is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 05 May 2017 (9+ years old) and is registered under CIN U73200KA2017PTC102838.
Mynvax reported revenue of ₹3.56 Cr for FY 2025 (up 26% YoY).
Mynvax has 6 current directors:
- Ganesh Murthy Kishore - Director
- Gautham Nadig - Director
- Mahendran Balachandran - Nominee Director
- Raghavan Varadarajan - Director
- Arun Suresh Chandavarkar - Director
- Anil Gudibande - Director
Mynvax reported a net loss of ₹22.58 Cr and EBITDA of -₹21.61 Cr for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mynvax is -15% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mynvax is 29AALCM0492J1Z0, registered in Karnataka.
The CIN (Corporate Identification Number) of Mynvax is U73200KA2017PTC102838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mynvax was incorporated on 05 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
Mynvax has 6 deals on record (5 funding rounds, 1 rights issue), with disclosed funding of ₹113.09 Cr; the latest was in May 2024.
The peers of Mynvax by revenue are Catalyst Clinical Services Private Limited, Azantis Life Sciences Private Limited, Elora Biosciences Private Limited, My Biotech Private Limited, Genext Biotech Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Mahendran Balachandran was appointed as Nominee Director on 07 Aug 2021. Arun Suresh Chandavarkar ceased to be Additional Director on 24 Jul 2021. Arun Suresh Chandavarkar was appointed as Director on 01 Jan 2021. Mynvax has 10 board changes on record in total.